DrugsControl Media Services
DrugsControl.org

News Detail

New Combination Drug for Endometrial Cancer Approved in EU (15-08-2024)

Brussels, 15 Aug 2024: The European Commission has approved a combination of an immunotherapy agent with a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of certain patients with primary advanced or recurrent View Details

Source : Medscape
European Commission combination of an immunotherapy agent with a poly (ADP-ribose) polymerase (PARP) inhibitor endometrial cancer

Related News